Beryl Drugs Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 7.57 | 5.47 | 3.85 |
| Operating Expense | 6.92 | 4.13 | 4.05 |
| Net Profit | 0.22 | 0.56 | -0.17 |
| Net Profit Margin | 2.91% | 10.24% | -4.42% |
| Earning Per Share | 0.44 | 1.11 | -0.33 |
| EBIDTA | 0.61 | 1.06 | 0.06 |
| Effective Tax Rate | 1.54% | 2.24% | 90.00% |
Particulars
Jun 2026
Revenue7.57
Operating Expense6.92
Net Profit0.22
Net Profit Margin2.91
Earning Per Share0.44
EBIDTA0.61
Effective Tax Rate1.54
